EcoDrugPlus

Ribosomal Protein S5

Ensembl ID : ENSSFOG00015027542
Gene Symbol: RPS5
3 Cross references
203 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSSFOG00015032644
Gene Symbol: RPS7
3 Cross references
349 Possible Orthologues:

Ribosomal Protein S8

Ensembl ID : ENSSFOG00015021328
Gene Symbol: RPS8
3 Cross references
325 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSSFOG00015000650
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein, Large, P1

Ensembl ID : ENSSFOG00015009860
Gene Symbol: RPLP1
1 Cross references
377 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-3-Like

Ensembl ID : ENSSFOG00015032904
Gene Symbol: LOC108920730
3 Cross references
136 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSSFOG00015017831
Gene Symbol: SERPINC1
3 Cross references
201 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSSFOG00015006056
Gene Symbol: LOC108941132
2 Cross references
320 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSSFOG00015008415
Gene Symbol: LOC108927073
2 Cross references
325 Possible Orthologues:

Sigma Non-Opioid Intracellular Receptor 1

Ensembl ID : ENSSFOG00015018122
Gene Symbol: SIGMAR1
3 Cross references
205 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSSFOG00015023737
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel, Voltage Gated, Type Xii, Alpha A

Ensembl ID : ENSSFOG00015023802
Gene Symbol: SCN12AA
1 Cross references
248 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).